 SAN DIEGO , Sept. 1, 2022 PRNewswire -- Avidity Biosciences, Inc. Nasdaq: RNA, a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates AOCsTM, today announced that the Avidity management team will be participating at the following upcoming conferences: 2022 Wells Fargo Healthcare Conference on Wednesday, September 7 at 1:20pm ET Chardan 6th Annual Genetic Medicines Conference on Tuesday, October 4 at 11:30am ET Live webcasts of each event, up-to-date event details and an archived replay of the webcasts following each event, will be available on the Events and Presentations page in the Investors section of Aviditys website at 